Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?

导出 OA

翻译打印收藏纠错

作者： David Charles,Hutchings ^[1] ; Simon George,Anderson ^[1] ; Jessica L,Caldwell ^[1] ; Andrew W,Trafford ^[1]

作者单位： Unit of Cardiac Physiology, Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. ^[1]

关键词 cardiac arrhythmias and resuscitation science cardiac risk factors and prevention coronary artery disease heart failure myocardial disease basic science

主题词心律失常, 心性(Arrhythmias, Cardiac);心脏(Heart);心力衰竭(Heart Failure);人类(Humans);肥大, 左心室(Hypertrophy, Left Ventricular);心肌梗死(Myocardial Infarction);磷酸二酯酶5抑制剂(Phosphodiesterase 5 Inhibitors)

DOI 10.1136/heartjnl-2017-312865

PMID 29519873

发布时间 2022-01-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览5

Heart (British Cardiac Society)

2018年104卷15期

1244-1250页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?

Heart (British Cardiac Society)

相似文献

Heart (British Cardiac Society)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?

Heart (British Cardiac Society)

相似文献

Heart (British Cardiac Society)

相关期刊

检索历史清除